12:00 AM
 | 
Jul 27, 2000
 |  BC Extra  |  Financial News

IPO triumvirate

Three IPOs priced on Thursday. Enzymes developer Genencor (GCOR) raised $126 million through the sale of 7 million shares at $18. The deal, which has a...

Read the full 112 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >